Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CapsoVision (CV) Cash & Equivalents (2024 - 2025)

CapsoVision's Cash & Equivalents history spans 2 years, with the latest figure at $10.1 million for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 8.51% to $10.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.1 million, a 8.51% increase, with the full-year FY2025 number at $10.1 million, up 8.51% from a year prior.
  • Cash & Equivalents hit $10.1 million in Q4 2025 for CapsoVision, down from $17.8 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for CV hit a ceiling of $17.8 million in Q3 2025 and a floor of $1.1 million in Q2 2025.